Publications by authors named "Zegui Tu"

Claim this Profile
G
Global epidemiological trend of cancer incidence and death in adults aged 60 years and older: a systematic analysis of data from GLOBOCAN 2022 and GBD2021.
Zegui Tu, Yang Yu, Caili Li, Qipeng Hu, Chengzhi Cai

BMC Geriatr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global epidemiological trends of trachea, bronchus, and lung cancer in the elderly.
Jintu Chen, Caili Li, Yang Yu, Shanghai Liu, Qipeng Hu, Zegui Tu

Cancer Epidemiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The long-term spatiotemporal trends in lung cancer burden and its risk factors at global, regional, and national levels, 1992-2021: The Global Burden of Disease Study 2021.
Zegui Tu, Shuangsi Liao, Caini Chen, Caili Li, Qipeng Hu

Cancer Commun (Lond)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 inhibitor abemaciclib combined with low-dose radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancer.
Laduona Wang, Yijun Wu, Kai Kang, Xuanwei Zhang, Ren Luo, Zegui Tu

Transl Lung Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An online clinical model and risk stratification system to predict progression-free survival for advanced non-small-cell lung cancer patients treated with PD-(L)1 inhibitor.
Zegui Tu, Yang Yu, Tian Tian, Caili Li, Jieyan Luo

Heliyon· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid response to monotherapy with MEK inhibitor trametinib for a lung adenocarcinoma patient harboring primary fusion: A case report and literature review.
Yang Yu, Min Yu, Yanying Li, Xiaojuan Zhou, Tian Tian, Zegui Tu

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A risk classification system predicting the cancer-specific survival for postoperative stage IB non-small-cell lung cancer patients without lymphovascular and visceral pleural invasion.
Zegui Tu, Caili Li, Tian Tian, Qian Chen

Lung Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Microtubule-Associated Proteins in Relation to Prognosis and Efficacy of Immunotherapy in Non-Small Cell Lung Cancer.
Jieyan Luo, Qipeng Hu, Maling Gou, Xiaoke Liu, Yi Qin, Zegui Tu

Front Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer.
Zegui Tu, Tian Tian, Qian Chen, Caili Li

J Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of epigenetic regulatory gene expression in patients with non-small-cell lung cancer.
Zegui Tu, Xiancheng Chen, Tian Tian, Guo Chen, Meijuan Huang

Aging (Albany NY)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis